Patrick Midoux

Dr. Patrick Midoux


Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2009 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
PMPatrick Midoux
Patrick Midoux
CPChantal Pichon
Chantal Pichon
JYJean‐Jacques Yaouanc
Jean‐Jacques Yaouanc
PJPaul‐Alain Jaffrès
Paul‐Alain Jaffrès
DNA/cationic lipid (lipoplexes), DNA/cationic polymer (polyplexes) and DNA/cationic polymer/cationic lipid (lipopolyplexes) electrostatic complexes are proposed as non‐viral nucleic acids delivery systems. These DNA‐nanoparticles are taken up by the cells through endocytosis processes, but the low capacity of DNA to escape from endosomes is regarded as the major limitations of their transfection efficiency. Here, we present a current report on a particular class of carriers including the polymers, peptides and lipids, which is based on the exploitation of the imidazole ring as an endosome destabilization device to favour the nucleic acids delivery in the cytosol. The imidazole ring of histidine is a weak base that has the ability to acquire a cationic charge when the pH of the environment drops bellow 6. As it has been demonstrated for poly(histidine), this phenomena can induce membrane fusion and/or membrane permeation in an acidic medium. Moreover, the accumulation of histidine residues inside acidic vesicles can induce a proton sponge effect, which increases their osmolarity and their swelling. The proof of concept has been shown with polylysine partially substituted with histidine residues that has caused a dramatic increase by 3–4.5 orders of magnitude of the transfection efficiency of DNA/polylysine polyplexes. Then, several histidine‐rich polymers and peptides as well as lipids with imidazole, imidazolinium or imidazolium polar head have been reported to be efficient carriers to deliver nucleic acids including genes, mRNA or SiRNA in vitro and in vivo. More remarkable, histidylated carriers are often weakly cytotoxic, making them promising chemical vectors for nucleic acids delivery.This article is part of a themed section on Vector Design and Drug Delivery. For a list of all articles in this section see the end of this paper, or visit: http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009

11 March 1999 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
PMPatrick Midoux
Patrick Midoux
MMMichel Monsigny
Michel Monsigny

1 April 2017 in Drug Discovery Today
Verified
Journal Article
Closed access
SBSarwar Beg
Sarwar Beg
MRMahfoozur Rahman
Mahfoozur Rahman
AJAtul Jain
Atul Jain
SSSUMANT SAINI
SUMANT SAINI
PMPatrick Midoux
Patrick Midoux
SASohail Akhter
Sohail Akhter

1 January 1993 in Nucleic Acids Research
Verified
Journal Article
Closed access
PMPatrick Midoux
Patrick Midoux
CMChristina Mendes
Christina Mendes
ALAlain Legrand
Alain Legrand
JRJacques Raimond
Jacques Raimond
RMRoger Mayer
Roger Mayer
ARAnnie Claude Roche
Annie Claude Roche
Plasmid DNA/glycosylated polylysine complexes were used to transfer in vitro a luciferase reporter gene into human hepatoma cells by a receptor-mediated endocytosis process. HepG2 cells which express a galactose specific membrane lectin were efficiently and selectively transfected with pSV2Luc/lactosylated polylysine complexes in a sugar dependent manner: i) HepG2 cells which do not express membrane lectin specific for mannose were quite poorly transfected with pSV2Luc/mannosylated polylysine complexes, ii) HeLa cells which do not express membrane lectin specific for galactose were not transfected with pSV2Luc/lactosylated polylysine complexes. The transfection efficiency of HepG2 cells with pSV2Luc/lactosylated polylysine complexes was greatly enhanced either in the presence of chloroquine or in the presence of a fusogenic peptide. A 22-residue peptide derived from the influenza virus hemagglutinin HA2 N-terminal polypeptide that mimics the fusogenic activity of the virus, was selected. In the presence of the fusogenic peptide, the luciferase activity in HepG2 cells was 10 fold larger than that of cells transfected with pSV2Luc/lactosylated polylysine complexes in the presence of chloroquine.

1 May 1996 in Experimental Cell Research
Verified
Journal Article
Closed access
PEPatrick Erbacher
Patrick Erbacher
ARAnnie Claude Roche
Annie Claude Roche
MMMichel Monsigny
Michel Monsigny
PMPatrick Midoux
Patrick Midoux

1 December 2001 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
CPChantal Pichon
Chantal Pichon
CGChristine Gonçalves
Christine Gonçalves
PMPatrick Midoux
Patrick Midoux